Southwest Airlines Co. may be at risk of a comment letter from the Securities and Exchange Commission after including adjusted revenue in its fourth-quarter earnings report published early Thursday.
Reports Q4 revenue $753M, consensus $740.91M. “Our Q4 results were toward the high end of our guidance range, driven by ...
Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...
Share Repurchase Program: During the fourth quarter of 2024, the company repurchased approximately 1.7 million shares at a total cost of approximately $325 million. During full year 2024, we ...
"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products ...
Q3 2025 Results Conference Call January 30, 2025 1:00 AM ETUnidentified Company RepresentativeThank you very much ...
At this time I would like to welcome everyone to the MasterCard Incorporated Q4 and full-year 2024 earnings conference call. [Operator instructions] Mr. Devon Corr, head of investor relations, you may ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.Cd03PSPW.js ...
(Nasdaq: NDAQ) today reported financial results for the fourth quarter and full year of 2024. 2024 net revenues 1 were $4.